Management of anticoagulation in patients with metastatic castration–resistant prostate cancer receiving abiraterone + prednisone
Author:
Publisher
Springer Science and Business Media LLC
Subject
Oncology
Link
http://link.springer.com/content/pdf/10.1007/s00520-019-04816-y.pdf
Reference68 articles.
1. Cooperberg MR, Chan JM (2017) Epidemiology of prostate cancer. World J Urol 35(6):849. https://doi.org/10.1007/s00345-017-2038-0
2. Torre LA, Bray F, Siegal RL et al (2015) Global cancer statistics, 2012. CA Cancer J Clin 65:87–108. https://doi.org/10.3322/caac.21262
3. Stein PD, Hull RD, Kayali F et al (2004) Venous thromboembolism according to age: the impact of an aging population. Arch Intern Med 164(20):2260–2265
4. Marinigh R, Lip GYH, Fiotti N, Giansanate C, Lane DA (2010) Age as a risk factor for stroke in atrial fibrillation patients: implications for thromboprophylaxis. JACC 56(11). https://doi.org/10.1016/j.jacc.2010.05.028
5. Khorana AA, Connolly GC (2009) Assessing risk of venous thromboembolism in the patient with cancer. J Clin Oncol 27:4839–4847. https://doi.org/10.1200/JCO.2009.22.3271
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. A new method to quantify the effect of co-medication on the efficacy of abiraterone in metastatic castration-resistant prostate cancer patients;Frontiers in Pharmacology;2023-09-28
2. Practical treatment guidance for cancer-associated thrombosis – Managing the challenging patient: A consensus statement;Critical Reviews in Oncology/Hematology;2022-03
3. Current thromboprophylaxis in urological cancer patients during COVID pandemic;Central European Journal of Urology;2022
4. Profils d’effets indésirables sous abiratérone et enzalutamide : analyse descriptive des données de la base nationale de pharmacovigilance;Therapies;2021-09
5. A Novel LC-MS Method for the Determination of Abiraterone in Rat Plasma and its Application to Pharmacokinetic Studies;Current Pharmaceutical Analysis;2021-08-16
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3